Accurate assessment
Treatment planning starts with what is actually being used, how often and what has happened during previous attempts to stop.
Heroin is an opioid. Repeated use can lead to strong physical dependence, cravings and a high risk of overdose, particularly when potency is uncertain or other sedating substances are involved. This page is for Pune families comparing heroin and explains residential-care, safety, travel and return-home questions with practical information for Pune families considering residential care.

Pune families can speak with True Humaniversity Foundation before making any travel or admission decision. Because residential treatment is a planned stay rather than a daily appointment, the right questions are clinical suitability, the programme itself, family communication, safety during travel and what support will continue after the person returns home.
Call before travelling: the team can first understand the substance or behaviour involved, current medicines, withdrawal or psychiatric concerns, previous treatment and what the family is trying to solve.
Heroin is an opioid. Repeated use can lead to strong physical dependence, cravings and a high risk of overdose, particularly when potency is uncertain or other sedating substances are involved.
Families do not always know the exact diagnosis, substance or reason the behaviour keeps returning. What they usually know is what has changed: sleep, work, money, relationships, self-care, trust or the amount of time the household spends responding to the latest incident.
Residential treatment can create distance from access and familiar cues while the programme works on opioid withdrawal, overdose risk and the routines surrounding heroin use.
Treatment planning starts with what is actually being used, how often and what has happened during previous attempts to stop.
Counselling looks at people, places, emotions, access and routines that repeatedly increase the risk of returning to use.
Money, access, trust and communication often need a clearer plan before discharge.
The resident prepares for situations that will return after treatment rather than assuming motivation will always stay strong.
The exact substance, dose, frequency, combinations, recent use, medicines and previous withdrawal matter. Some drug withdrawals or acute reactions require medical assessment before residential rehabilitation.
Residential treatment offers structure, but the outside world eventually comes back. Work pressure, money, relationships, old friends, easy access, difficult emotions and periods of low motivation can all reappear.
Before discharge, the person and family should understand the situations most likely to create difficulty. A useful plan is specific: what warning signs matter, what boundaries need to exist, who should be contacted, what continuing treatment is needed and what should happen if symptoms or addictive behaviour begin returning.
Pune families can discuss the situation before travelling. If residential care is suitable, the team can explain admission, practical arrangements, family communication and what should continue after the person returns home.
Tell the team about the exact opioid if known, last use, overdose history, very slow breathing or loss of consciousness, previous withdrawal, pain treatment and any alcohol or sedative use. A Pune family should not begin a journey while an overdose or other acute emergency is unfolding.
Some people have previously detoxified, taken medicines for opioid-use disorder or relapsed after a period of abstinence. Those details affect the next plan. Evidence-based medical treatment and psychosocial rehabilitation should not be presented as competing choices when both may be relevant.
Once immediate medical risk is addressed, the work shifts to craving, access to opioids, old contacts, pain, money, family patterns and the situations in which use repeatedly returns. The family should know what the programme will actually work on during the stay.
Tolerance can fall during abstinence. A return to previous opioid amounts can therefore be especially dangerous. Discharge planning should cover ongoing medical care, relapse warning signs, access to drugs and what the family should do if use resumes.
With heroin, the immediate dangers and the longer recovery problem are tightly linked. Families may be dealing with tolerance, withdrawal, repeated relapse, injection-related risks, mixing with alcohol or tablets, and the possibility that a return to use after a period of abstinence can be especially dangerous.
Any previous overdose, reduced consciousness, very slow breathing or emergency naloxone use should be disclosed. A residential programme should understand the person’s overdose history and should not pretend that counselling alone replaces appropriate medical addiction treatment.
Getting through withdrawal does not remove craving, old contacts, availability, stress or the learned expectation of relief from opioids. Longer-term treatment has to plan for those pressures after the acute phase.
Qualified clinicians may consider medicines used in opioid-use treatment depending on the individual situation. Residential rehabilitation should work alongside appropriate medical care rather than requiring people to choose between psychosocial support and evidence-based medical treatment.
After a period without heroin, tolerance can fall. That makes return to previous amounts particularly risky. Discharge planning should discuss relapse risk, emergency response and ongoing medical care rather than treating discharge as proof that danger has passed.
Pune and the Mumbai region are close enough that residential care is often compared across both markets. Speak with the team before travelling so safety, admission suitability, family communication and the plan for returning home are understood first.
No. Withdrawal management is one stage. The longer work involves craving, triggers, relationships, access to drugs, mental health, overdose prevention and continuing treatment.
Tell the team immediately. A previous overdose is a major safety signal and should influence assessment, medical planning and discharge discussions.
Yes, evidence-based opioid treatment may include medicines prescribed and monitored by qualified clinicians. Rehabilitation should coordinate with appropriate medical care where needed.
Tolerance can fall during abstinence. Returning to an amount previously used can therefore carry a greater overdose risk.
Withdrawal management may be necessary, but opioid-use disorder often needs longer-term treatment, overdose prevention, behavioural support and continuing medical care.
Not simply because residential treatment is being considered. Evidence-based medication treatment should be reviewed with qualified medical professionals and integrated with recovery care where appropriate.
Yes. Call first and describe the situation. The team can discuss suitability, current health or withdrawal concerns, the residential programme, practical arrangements and the return-home plan before travel is organised.
Not automatically. Acute medical or psychiatric risks may need local emergency or hospital assessment before travel. Describe the current situation before making the journey.
Discharge should identify continuing medical, psychiatric or counselling care where needed, family boundaries, warning signs and who will coordinate the next stage after the residential stay.
You do not need to know the right treatment term before calling. Explain the pattern, what has changed and what worries the family most.